✦ LIBER ✦

Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients

✍ Scribed by Raffaele Marfella; Carlo Luongo; Antonino Coppola; Margherita Luongo; Paola Capodanno; Roberto Ruggiero; Luigi Mascolo; Immacolata Ambrosino; Celestino Sardu; Virginia Boccardi; Biagio Lettieri; Giuseppe Paolisso

Book ID: 118422697
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 559 KB
Volume: 208
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2009.08.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of a Constitutively Active Hypoxia-I

Use of a Constitutively Active Hypoxia-Inducible Factor-1 Transgene as a Therapeutic Strategy in No-Option Critical Limb Ischemia Patients. Phase I Dose-Escalation Experience

✍ Rajagopalan, S.; Olin, J.; Deitcher, S.; Pieczek, A.; Laird, J.; Grossman, P. M. 📂 Article 📅 2007 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 821 KB